go-v.orgdoi

HT update: spotlight on estradiol/norethindrone acetate combination therapy

Colleen Casey, Christine A Murray · Clinical Interventions in Aging · 2008

  • DOI 10.2147/cia.s1663
  • Publisher Dove Medical Press
  • Type article
  • Issued 2008

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Interventions in Aging · Dove Medical Press · article · 2008

Abstract

Abstract: The goal ofpostmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin replacement. The purpose of this review is to describe the risks and benefits of hormonal therapy, focusing on estradiol/norethindrone acetate combination therapy.

Open the resolved locator · 10.2147/cia.s1663

Metadata licence: OpenAlex metadata (CC0)